THURSTON, SPRINGER, MILLER, HERD & TITAK, INC.
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 319933
INDIANAPOLIS, IN
Position in NAMS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$36,160
+$2,006 QoQ
Shares Held
1,067
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#171
of 196 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. holds $361,152 across 14 Biotechnology names. NAMS ranks #4 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
1,637 | $89,271 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
236 | $74,588 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
254 | $61,194 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
1,067 | $36,160 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
63 | $31,291 | |
| 6 | RPRX |
Royalty Pharma plc
|
393 | $22,035 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
455 | $16,102 | |
| 8 | MRNA |
Moderna, Inc.
|
145 | $10,153 |
All Filings in NAMS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,160 | 1,067 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $34,154 | 1,067 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $37,430 | 1,067 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $30,345 | 1,067 | Shares | Sole | 2025-10-07 | |
| No filing history on record for this holder in this stock. | ||||||